Following the theoretical expectation that increasing the number of subjects may be the key to discover markers associated to AD, GWAS have been showing a clear trend to increase the number of analyzed subjects, the most recent including subjects whose AD status was established by proxy ( Figure 1A ).
← all excerpts
Navigating the blurred boundary: Neuropathologic changes versus clinical symptoms in Alzheimer's disease, and its consequences for research in genetics.
1
—
—